FREE NEWSLETTER

Two India data points published this week tell very different stories about the same market

Two pieces of India data were published this week that sit at complete odds with each other – and the tension between them is precisely what anyone evaluating India as an export market or growth priority needs to understand.

On 22 July 2026, United Spirits Limited – Diageo’s Indian subsidiary and India’s largest alcoholic beverages company – reported first-quarter FY2027 results showing net profit up 51.6% year on year and premium segment net sales up 10.1%. Premium brands accounted for 91.7% of United Spirits’ net sales during the quarter. The Indian premium spirits consumer is not a projection. It is a confirmed, growing, current commercial reality.

Also on 22 July 2026, Pernod Ricard withdrew its petition to the Delhi High Court challenging India’s $314 million back tax demand over the alleged undervaluation of Scotch whisky imports. The case is dismissed as withdrawn. Pernod will pursue the statutory appeal route instead. The dispute is not resolved. It has moved to a longer, less certain process – in a market that Pernod’s own leadership has described as the company’s future largest single global market.

Both things are true in the same week. The Indian premium spirits market is growing strongly. One of the two largest spirits companies operating in it is simultaneously managing a $314 million tax dispute, a Delhi licence suspension, and an antitrust investigation. The opportunity and the risk are not sequential. They are present simultaneously.

Why both data points matter – and why neither alone is sufficient

The India market has generated two types of coverage in the drinks industry in 2026. The first type focuses on the opportunity: rising incomes, the world’s largest whisky market by volume, a young legal-drinking-age population, the UK-India FTA entering into force on 15 July with the federal Scotch whisky tariff falling from 150% to 75%.

Free newsletter
Daily drinks industry intelligence. No subscription needed.
Continue reading
Start your 30-day trial for £1 / $1 / €1. Cancel anytime.
  • -Daily coverage
  • -Market and category analysis
  • -Financial results coverage
  • -Practical industry guides
  • -Interviews
  • -Monthly intelligence briefing
Start 30-day trial - £1 / $1 / €1
Already a member? Sign in here.